Breast cancer stage II
Information
- Disease name
- Breast cancer stage II
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03927027 | Active, not recruiting | Phase 3 | Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection | July 29, 2019 | January 2026 |
| NCT03766009 | Active, not recruiting | N/A | Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making | March 1, 2019 | December 15, 2023 |
| NCT03384914 | Active, not recruiting | Phase 2 | Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer | February 19, 2018 | December 2026 |
| NCT04180579 | Active, not recruiting | N/A | Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients | November 26, 2019 | May 2025 |
| NCT03609047 | Active, not recruiting | Phase 2 | Adjuvant Palbociclib in Elderly Patients With Breast Cancer | June 14, 2019 | September 30, 2032 |
| NCT00393341 | Completed | Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer | October 2006 | August 2009 | |
| NCT01599039 | Completed | Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema | May 2012 | January 2016 | |
| NCT02335671 | Completed | N/A | Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy | February 2015 | January 2023 |
| NCT02639208 | Completed | N/A | Novel Social Media Intervention For Older Br CA Patients | February 8, 2016 | August 6, 2021 |
| NCT03578627 | Completed | N/A | Stress and Immunity Breast Cancer Project | May 1, 1994 | May 31, 2000 |
| NCT05180656 | Completed | N/A | Feasibility of a Remotely-Delivered Yoga Intervention on Cognitive Function in Breast Cancer Survivors | December 13, 2021 | July 27, 2022 |
| NCT06268665 | Not yet recruiting | Phase 2 | Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | February 28, 2024 | June 2027 |
| NCT06336538 | Not yet recruiting | N/A | Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors | July 1, 2024 | January 31, 2025 |
| NCT06407401 | Not yet recruiting | Phase 3 | Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Women With Early Breast Cancer | December 2024 | November 30, 2028 |
| NCT05724758 | Not yet recruiting | Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery | March 1, 2023 | September 1, 2024 | |
| NCT05036252 | Recruiting | Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity | August 27, 2021 | August 27, 2024 | |
| NCT05190770 | Recruiting | Phase 2 | A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer | December 15, 2021 | December 15, 2026 |
| NCT05288777 | Recruiting | Phase 2/Phase 3 | Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer | July 11, 2022 | October 2026 |
| NCT05296746 | Recruiting | Phase 2 | Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer | May 3, 2022 | July 1, 2030 |
| NCT05406531 | Recruiting | N/A | The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors | June 6, 2022 | June 2025 |
| NCT05528263 | Recruiting | N/A | Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) | September 8, 2022 | February 28, 2026 |
| NCT05558722 | Recruiting | Phase 2 | Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer | November 30, 2022 | July 30, 2025 |
| NCT03270072 | Recruiting | The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients | October 26, 2017 | December 31, 2027 | |
| NCT03879577 | Recruiting | Phase 2 | Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer | November 25, 2019 | April 10, 2024 |
| NCT04720209 | Recruiting | N/A | Taking AIM at Breast Cancer | August 13, 2021 | June 15, 2026 |
| NCT05020860 | Recruiting | Phase 2 | Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer | April 18, 2023 | November 2029 |
| NCT05898789 | Recruiting | N/A | Virtual Rehabilitation for Cancer Survivors | July 7, 2023 | February 2025 |
| NCT05912231 | Recruiting | N/A | Ultrahypofractionation and Normal Tissue Toxicity | August 15, 2023 | September 17, 2025 |
| NCT06006806 | Recruiting | N/A | Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy | July 7, 2023 | July 7, 2027 |
| NCT06275126 | Recruiting | N/A | Optimizing Surgical Decisions in Young Adults With Breast Cancer | March 13, 2024 | May 2027 |
| NCT05828238 | Recruiting | Early Phase 1 | Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy | January 2023 | January 2024 |
| NCT05877859 | Recruiting | Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab | May 30, 2023 | April 10, 2026 | |
| NCT03723863 | Terminated | N/A | Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy | October 25, 2018 | September 22, 2020 |
| NCT01352494 | Unknown status | Phase 2 | Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer | May 2011 | May 2015 |
| NCT05774886 | Withdrawn | Phase 1 | Implantable Microdevice for TNBC - Pilot Study | May 2023 | September 1, 2028 |
| NCT03058939 | Withdrawn | Phase 2 | Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer | November 2018 | June 2019 |